Cargando…
New metabolic signature for Chagas disease reveals sex steroid perturbation in humans and mice
The causative agent of Chagas disease (CD), Trypanosoma cruzi, claims thousands of lives each year. Current diagnostic tools are insufficient to ensure parasitological detection in chronically infected patients has been achieved. A host-derived metabolic signature able to distinguish CD patients fro...
Autores principales: | Golizeh, Makan, Nam, John, Chatelain, Eric, Jackson, Yves, Ohlund, Leanne B., Rasoolizadeh, Asieh, Camargo, Fabio Vasquez, Mahrouche, Louiza, Furtos, Alexandra, Sleno, Lekha, Ndao, Momar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800200/ https://www.ncbi.nlm.nih.gov/pubmed/36590505 http://dx.doi.org/10.1016/j.heliyon.2022.e12380 |
Ejemplares similares
-
Dataset from proteomic analysis of rat, mouse, and human liver microsomes and S9 fractions
por: Golizeh, Makan, et al.
Publicado: (2015) -
Validation of Apolipoprotein A-1 and Fibronectin Fragments as Markers of Parasitological Cure for Congenital Chagas Disease in Children Treated With Benznidazole
por: Ruiz-Lancheros, Elizabeth, et al.
Publicado: (2018) -
Protein Targets of Acetaminophen Covalent Binding in Rat and Mouse Liver Studied by LC-MS/MS
por: Geib, Timon, et al.
Publicado: (2021) -
Serological and parasitological response in chronic Chagas patients 3 years after nifurtimox treatment
por: Jackson, Yves, et al.
Publicado: (2013) -
Serum biomarkers predictive of cure in Chagas disease patients after nifurtimox treatment
por: Santamaria, Cynthia, et al.
Publicado: (2014)